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Despite the increase in surgical volumes of live liver donation, there has been very little documentation of the postoperative 
pain experience. The primary aim of this study was to examine the difference in acute postoperative pain intensity and 
adverse effects between patients who received intravenous patient-controlled analgesia (IV PCA) or patient-controlled epi-
dural analgesia (PCEA) for pain control after live liver donation surgery. A retrospective chart review was performed of 226 
consecutive patients who underwent right living donor hepatic surgery at the Toronto General Hospital, Toronto, Canada. 
Patients who received as their primary postoperative analgesic modality IV PCA (n ¼ 158) were compared to patients who 
received PCEA (n ¼ 68). Demographic profiles for the 2 groups were similar with respect to age, sex, and body mass index 
at the time of surgery. For the first 3 postoperative days, pain intensity was significantly lower in patients who received epi-
dural analgesia (P < 0.01). Clinically significant moderate pain (defined as a Numeric Rating Scale pain score >4) was 
reported more frequently in the IV PCA group (P < 0.05) along with increased sedation (P < 0.05). Pruritus was reported 
more frequently in the PCEA group of patients compared to the IV PCA group (P < 0.05). Significant between-group differ-
ences were not found for the incidence of postoperative vomiting, the time at which patients began fluid intake, the time to 
initial ambulation, or the length of hospital stay. In conclusion, epidural analgesia provides better postoperative pain relief, 
less sedation, but more pruritus than IV PCA after live liver donation. 
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Live liver donation has become a viable option for liver
transplantation.1 Advances in surgical techniques
and anesthesia safety have made live liver donation a
safe procedure.2,3 Early studies examining live liver
donation revealed that appropriate patient selection
was a critical factor in preventing postoperative com-
plications.4,5 Therefore, before donating a liver, the
donor undergoes extensive preoperative screening to
ensure patient safety.5 Psychosocial predictors of do-
nor outcomes, as well as the financial, vocational, and
interpersonal impact of live liver donation have been
recently reported.6,7
Opioid-based analgesia has been the modality of
choice for perioperative analgesia after right live donor
hepatectomy (RLDH) because opioids are useful in the
treatment of moderate to severe pain.8,9 Standard
perioperative pain management practice often relies
on opioids as the primary pain medication via the
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administration of intravenous patient-controlled anal-
gesia (IV PCA). However, opioids tend to be ineffective
for pain that is associated with movement and have
significant short-term side effects including nausea,
vomiting, sedation, pruritus, constipation, urinary
retention, and respiratory depression,10 which are
factors that often hinder a patient’s recovery. Epidural
analgesia has become an accepted alternative to IV
PCA. Prospective randomized trials have found epidu-
ral analgesia to be superior to IV PCA in several surgi-
cal populations.11-13
The physiologic effects of thoracic epidural anesthe-
sia on the cardiovascular, respiratory, and gastroin-
testinal systems have been well documented.14-16 Epi-
dural analgesia works by inhibiting afferent impulses,
blunting neuronal transmission from the periphery to
the central nervous system and by inhibiting sodium
channels at the level of the spinal cord.15,17 Two sys-
tematic reviews have demonstrated that epidural
analgesia provides superior pain relief up to 72 hours
after intra-abdominal surgery when compared to IV
PCA.18,19 Studies have demonstrated that epidural
analgesia is associated with fewer postoperative pul-
monary complications and lower postoperative opioid
consumption.15,16 The use of epidural analgesia has
also been associated with early return of bowel func-
tion, a shorter length of stay in hospital,15,16,20-22
enhanced functional exercise capacity, and better
health-related quality of life.23
Although effective postoperative pain management
is of great importance to patients, there have been few
reports documenting postoperative pain intensity after
live liver donation.24-26 One study, which compared
patients who underwent right lobe donor hepatectomy
with patients who had undergone major hepatic resec-
tion for tumor, found that patients who underwent
RLDH had significantly more intense pain and were
2.76 times more likely to report increased pain at all
postoperative time points.24 Studies have prospec-
tively examined postdonation changes in health-
related quality of life after liver donation surgery.27-29
Of these prospective studies, only 1 addressed postop-
erative pain, and the authors reported that the
patient’s anticipation of their postoperative pain was
far worse than their actual experience of it.28 The
authors recommended further study of postoperative
pain after live liver donation surgery.
Despite the potential advantages of epidural analge-
sia, the risk of an extremely rare but significant com-
plication such as an epidural hematoma has led sev-
eral transplant centers to abandon the use of epidural
analgesia.1 However, there has been minimal pub-
lished evidence with respect to epidural use in the live
liver donor population. The abandonment of epidural
use in this highly functioning population is a decision
that should not be taken lightly. Detailed documenta-
tion of these patients’ postoperative pain experiences
and the effect of postoperative pain on their subse-
quent quality of life is an important outcome yet to be
investigated.
The primary aim of this study was to examine dif-
ference in postoperative pain intensity and adverse
effects between patients who received IV PCA or
patient-controlled epidural analgesia (PCEA) for pain
control after live liver donation surgery. A secondary
aim was to determine whether postoperative compli-
cations and length of hospital stay differed signifi-
cantly between patients that received IV PCA or
PCEA.
PATIENTS AND METHODS
The study was reviewed and approved by the
Research Ethics Board of the Toronto General Hospi-
tal, University Health Network, Toronto, Canada. We
performed a retrospective analysis of pain intensity
scores, analgesic consumption, and postoperative side
effects after live liver donation. The Toronto General
Hospital is a major liver transplant center, which per-
forms more than 120-150 liver transplants annually.
Live liver donation accounts for one-third of all organ
transplants at our institution (150 of 490 trans-
plants). Consecutive patients who had undergone
elective RLDH surgery between April 2004 and Janu-
ary 2009 (n ¼ 226) were identified using institutional
electronic databases. A total of 158 patients received
IV PCA, and the other 68 patients received PCEA devi-
ces for control of postoperative pain. Prior to attend-
ing the preoperative anesthesia consultation clinic
TABLE 1. Baseline Characteristics Prior to the Initiation of Postoperative Pain Modality
Variable
Group
i.v. patient-controlled
analgesia (N ¼ 158)
Patient-controlled
epidural analgesia (N ¼ 68)
Age (years) 36.4 6 11.5 36.2 6 11.1
Sex (M/F) 76 / 82 28 / 40
Body mass index (BMI) 25.2 6 3.9 25.1 6 3.8
Intraoperative fentanyl (lg) 478.9 6 205.4* 311.32 6 171.1*
Intraoperative morphine (mg) 9.6 6 7.9* 2.1 6 3.6*
Data are mean 6 SD. Asterisk (*) represents significant difference between groups (P < 0.001).
visit, patients were seen by their attending surgeon.
Following that encounter, all patients were booked for
a preoperative anesthesia consultation. At the anes-
thesia assessment visit, all risks/benefits of placing
an epidural catheter (ie, infection, hypotension, pos-
tural dizziness, risk of epidural hematoma leading to
paralysis) versus IV PCA (nausea, vomiting, urinary
retention, and ileus and respiratory depression) peri-
operatively were discussed with each individual
patient. Patients were not asked to choose between
the postoperative pain modalities at that visit. Rather,
they were asked to think about it and inform their
anesthesiologist on the morning of surgery whether
they wanted a PCEA or an IV PCA for postoperative
pain control. Electronic documents of all identified
patients were made available and reviewed.
The perioperative pain management protocol for liv-
ing donor hepatectomy is standardized. Patients who
consented to receive a thoracic epidural had the cath-
eter placed in the sitting position before induction of
anesthesia. The standard site of epidural catheter
placement is typically between thoracic levels T7 to
T10. A standardized test dose of 3 mL of 2% lidocaine
was injected to confirm appropriate epidural
placement.
All patients had standard Canadian Anesthesiology
Society monitors placed for surgery and were moni-
tored using a radial arterial blood pressure trans-
ducer and internal jugular central venous pressure
transducer. General anesthesia was induced using
1-2 mg/kg body weight of propofol, 1-2 lg/kg of
fentanyl, and a nondepolarizing muscle relaxant to
facilitate endotracheal intubation. The triple lumen
central venous catheter was placed under ultrasound
guidance (Sonosite; Bothell, WA). The central venous
pressure was maintained between 2 and 6 mm Hg
during liver resection. General anesthesia was main-
tained with a volatile anesthetic agent (isoflurane, sev-
oflurane, or desflurane). PCEA infusions were typi-
cally commenced within the first 2 hours after the
start of surgery. For patients who were to receive IV
PCA for postoperative pain control, intraoperative
opioid boluses were given at the discretion of the
attending anesthesiologist. For those patients who
received epidural analgesia, epidural pumps were pre-
pared by our postanesthetic care unit (PACU) on the
morning of surgery and brought to the operating
room. Typically, we do not receive the epidural pumps
until patients are anesthetized and positioned for sur-
gery. Other than the initial bolus of 3-5 mL of lido-
caine into the epidural to confirm that the catheters
were not intrathecal, boluses are kept to a minimum
intraoperatively. The practice at our institution is to
run the epidurals during the surgery because it also
helps to decrease the central venous pressures, which
helps to minimize blood loss. After surgery, all
patients were extubated in the operating room or
PACU. Shortly after arriving in the PACU, all patients
were given a hand-held push-button that controlled
the PCEA or IV PCA device, and recording of their an-
algesic consumption was begun. All patients were
transferred to the surgical step-down ward upon dis-
charge from the PACU.
The Acute Pain Service (APS) at the Toronto General
Hospital has standardized algorithms for managing
postoperative pain. Patients with thoracic epidurals
placed below the T6 dermatome received a 0.1% bu-
pivacaine solution with 0.015 mg/mL hydromor-
phone. The epidural infusion was delivered via an
Abbott GemStar (Hospira, Lake Forest, IL) pump at a
rate of 5 mL/hour (with a 3 mL bolus, 20-minute
lockout period, and a 4-hour maximum of 50 mL).
Patients in the PCEA group were not given IV opioids
during the acute postoperative period. IV PCA was
administered with an Abbott LifeCare PCA II (Hospira,
Lake Forest, IL) pump using a hydromorphone con-
centration of 0.4 mg/mL boluses at a dose of 0.2-0.4
mg with a 5-minute lockout period and a 4-hour max-
imum of 10 mg or using a morphine concentration of
1 mg/mL boluses at a dose of 1.0-2.0 mg with a 5-mi-
nute lockout period and a 4-hour maximum of 40 mg.
Patients received both hydromorphone and morphine
IV PCA pumps. We converted opioid consumption use
into morphine equivalents. The number of patients
varies in Fig. 1 due to the inherent issues with retro-
spective reviews, because not all patients provided
data at every time point. Acetaminophen is not pre-
scribed to living related donors until the surgeons are
comfortable with liver function. Nonsteroidal anti-
inflammatory drugs are also not routinely prescribed
in the early postoperative period.
Pain intensity was measured with a numeric rating
scale (NRS). The NRS consists of a series of numbers
ranging from 0 to 10 with endpoints representing the
most extreme pain experiences (0 ¼ no pain and 10 ¼
worst possible pain). The NRS has been shown to
have good reliability and validity and is sensitive to
change following pharmacological intervention.30 Clin-
ically significant moderate pain is defined as a score
greater than 4 out of 10, with severe pain being
reported as pain greater than 6 out of 10 on the
NRS.31,32 Pain intensity was measured using the NRS
every 4 hours by the attending nursing staff following
surgery until discharge from the APS. The APS
reviewed each patient a minimum of 2 times per day
while the epidural was in situ and once per day while
the IV PCA was in use. If patients reported a pain
score equal to or greater than 5 of 10 on 2 consecutive
time points (after having been assessed by the ward
nurse and deemed to be using the PCEA or IV PCA de-
vice adequately), the patient’s attending nurse paged
the APS physician, who then visited the patient and
adjusted the epidural rate or the IV PCA settings as
needed to ensure patient comfort.
Data from the postoperative period was manually
obtained from the scanned version of the paper chart,
including APS records (ie, postoperative analgesic
mode [IV PCA versus PCEA], pain intensity scores,
volume of epidural solution infused, opioid consump-
tion, side effects [sedation, pruritus, nausea, and
vomiting] and the duration of patient care by the
APS), physiotherapy notes (day of ambulation),
nursing documentation records (diet advancement),
and drug administration record (supplemental analge-
sic use). Data were obtained at specific daily time
points of 06:00, 12:00, 18:00, and 24:00 when under
the care of the APS. Pain scores were collected from
postoperative day (POD) 0 (day of surgery) until
patients were discharged from the APS. Demographic
information including sex, age, height, and weight
were also recorded from the electronic records. All
patients received an American Society of Anesthesiolo-
gists classification score of 1 or 2.
The presence or absence of sedation, nausea, vomit-
ing, and pruritus was recorded from the electronic
records. We also recorded the time to achieve initial
ambulation, when oral fluid intake first occurred, and
the date of hospital discharge.
Statistical Analysis
The primary outcome variable of interest was pain
intensity scores across the first 3 days after surgery.
For each patient, we computed 2 measures of area
under the pain curve (AUPC): (1) Time 1: from POD0
18:00 to POD1 24:00 (total of 6 time points covering
30 hours) (2) Time 2: from POD1 24:00 to POD3
06:00 (total of 6 time points covering 30 hours). In
computing the AUPC, patients were excluded if they
(1) had more than 2 pain scores missing during the
time period or (2) were missing pain scores for 2 or
more consecutive time points. For the remaining
patients, missing pain scores were imputed by calcu-
lating the mean of the pain scores of the adjacent
time points.
For the comparison of AUPC values between the 2
treatment groups, the analysis was adjusted for
potential confounding factors. This was particularly
important because the study was not a randomized
controlled trial and potential biases between the
groups were therefore minimized by statistically con-
trolling for age, sex, and surgeon via stratification
using the nonparametric Aligned Rank test.33 This
test is known to be more powerful than the van Elte-
ren test.34 For the stratification according to age, the
data were dichotomized based on the median age
value. For the comparison of adverse events, the data
were dichotomized representing presence or absence
of sedation, nausea, vomiting, and pruritus.
Demographic and clinical variables were compared
between the two groups using Wilcoxon test for con-
tinuous (or ordinal) variables and Fisher’s exact test
Figure 1. Effects of postoperative analgesic modality on postoperative pain. Data are expressed as mean 6 standard error of the
mean. Postoperative pain intensity was significantly lower in patients who received epidural analgesia. The AUPC was significantly
lower in patients who received epidural analgesia versus those who received IV PCA throughout both Time 1 (P ¼ 0.00005) and Time 2
(P ¼ 0.019).
for categorical variables. All calculations were performed
using SAS statistical software package version 9.2 (SAS
Institute, Inc., Cary, NC) and R software environment
version 2.10 (The R Foundation for Statistical Comput-
ing, Vienna, Austria), under the Microsoft Windows XP
Professional (version 2002, Service Pack 3; Microsoft
Corp., Redmond, WA) operating system.35
RESULTS
The patients receiving postoperative epidural analge-
sia and those receiving IV PCA were similar with
respect to age, sex, and body mass index. Patients
who chose IV PCA for postoperative pain control
received significantly more intraoperative opioids than
patients who opted for a PCEA (P < 0.001; Table 1).
Pain Scores
Figure 1 shows the NRS pain scores across the 2 time
periods as well as the IV PCA and PCEA groups’ con-
sumption of analgesics/epidural solution. Overall,
postoperative pain was better controlled with the use
of epidural analgesia. The AUPC was significantly
smaller in patients who received PCEA versus IV PCA
throughout both Time 1 (P < 0.00005) and Time 2
(P ¼ 0.019). The analysis shows that postoperative
pain was significantly less intense from POD0 to the
morning of POD3 for patients who received epidural
analgesia as their primary pain modality. In order to
control for possible bias within this retrospective
database, a secondary analysis of pain scores which
were stratified for age, sex, and surgeon also demon-
strated that the AUPC was significantly smaller in
patients who received PCEA versus IV PCA for both
Time 1 (P < 0.0001 all time points) and Time 2 (P ¼
0.05 all time points; Table 2).
Clinically Significant Moderate Pain
Clinically significant moderate pain, defined as an
NRS score greater than 4,31 was reported significantly
less often in the epidural group than the IV PCA group
at POD0 24:00 (P < 0.01), POD1 06:00 (P < 0.05),
POD1 12:00 (P < 0.05), and POD1 24:00 (P < 0.01;
Table 3)
Adverse Effects
Sedation was present more often in the IV PCA group
when compared to patients who received PCEA at var-
ious time points until the morning of POD3 (Table 4).
The reported incidence of pruritus was higher in the
PCEA group (Table 5). Patients who received PCEA
also demonstrated a higher incidence of nausea on
the morning of POD3 (Table 6). Vomiting rarely
occurred, and the incidence did not differ significantly
between the groups.
Hospital-Based Outcomes
Table 7 demonstrates that significant intergroup dif-
ferences were not found with respect to the time that
oral fluid intake was initiated, the time to initial
ambulation, or the length of hospital stay.
TABLE 2. Stratified Analysis of Age, Sex, and Surgeon
AUPC
Stratifying Factors (P Values)
Age þ Sex Age þ Surgeon Sex þ Surgeon
Time 1 <0.0001* <0.0001* <0.0001*
Time 2 0.0369* 0.0212* 0.0267*
*P < 0.05 at all time points, pain was significantly lower
in patients that received PCEA vs. i.v. PCA across both
Time 1 and Time 2 regardless of the variables tested.
TABLE 3. Number of patients in the i.v. PCA and PCEA groups that reported numeric rating scale pain intensity scores
> 4. Data were analyzed by Fisher’s exact test
Postoperative
Day and Time
i.v. PCA
No./Total (%)
PCEA
No./Total (%) P Value*
POD0 18:00 42/123 (34) 14/58 (24) 0.23
POD0 24:00 29/139 (21) 3/62 (5) 0.003*
POD1 06:00 37/153 (24) 7/65 (11) 0.026*
POD1 12:00 36/142 (25) 4/62 (6) 0.002*
POD1 18:00 23/141 (16) 6/64 (9) 0.28
POD1 24:00 15/124 (12) 0/57 (0) 0.003*
POD2 06:00 29/142 (20) 8/61 (13) 0.24
POD2 12:00 19/112 (17) 6/51 (12) 0.49
POD2 18:00 19/116 (16) 5/50 (10) 0.34
POD2 24:00 16/98 (16) 3/43 (7) 0.18
POD3 06:00 13/104 (13) 4/47 (9) 0.59
Abbreviations: i.v. PCA, intravenous patient-controlled analgesia; PCEA, patient-controlled epidural analgesia; POD,
postoperative day.
*Indicates significant difference p<0.05.
DISCUSSION
Given the excellent health status and high functional
disposition of live liver donors, the pain experienced
upon awakening from surgery is often the patient’s
first experience with significant pain. Throughout the
early postoperative time period, patients using IV PCA
devices reported significantly more intense pain com-
pared to patients who received PCEA (Fig. 1).
Although the mean pain scores depicted in Fig. 1 are
by and large below an NRS score of 3, we further
examined each time point with respect to the number
of patients who reported moderate pain (ie, NRS > 4
out of 10).36 The NRS cut-point corresponding to the
transition from mild to moderate pain occurs when a
patient reports a pain score greater than 4 out of 10;
the cut-point for moderate to severe pain corresponds
to an NRS pain score greater than 6 out of 10.31,32,37
Table 3 demonstrates that until POD2, significantly
more patients in the IV PCA group reported more clin-
ically significant postoperative pain (ie, reported pain
scores greater than 4 out of 10) than did patients in
the PCEA group. Severe pain was a very rare occur-
rence in both groups. Given that the P value for Time
2 (P ¼ 0.019) in Fig. 1 demonstrates less overall sig-
nificance than the P value of Time 1 (P < 0.00005), we
accept the criticism that the difference in postopera-
tive pain demonstrated at Time 2 may or may not be
of clinical significance. The significant between group
difference in intraoperative opioid administration
(Table 1) may have also contributed to the greater
postoperative pain scores in the IV PCA group. Evi-
dence shows that opioids, such as fentanyl, paradoxi-
cally activate pronociceptive systems associated with
acute opioid tolerance and opioid-induced hyperalge-
sia.38-41 Thus, it is possible that the more intense
pain in the IV PCA group may be due, in part, to the
greater systemic dose of intraoperative opioids, in
particular fentanyl.
The limited literature evaluating the effect of differ-
ent modes of postoperative analgesia among live liver
donors is not surprising because this surgery has a
relatively short history. Yong and colleagues found no
difference in the intensity of postoperative pain
between those receiving epidural analgesia when com-
pared to those receiving IV PCA.25 Cywinski and col-
leagues demonstrated that live liver donor patients
had more significant pain as compared to patients
with liver malignancies.24 The authors attributed the
lack of adequate pain control in the live donors to the
increased surgical time and to the lack of appropriate
nursing care/knowledge with respect to the PCEA
devices.24
Millions of patients undergo surgery on an annual
basis in North America to remedy diseased states.42
However, surgery for living organ donation is different
in many respects. Healthy patients subject themselves
to an otherwise unnecessary surgery for an altruistic
cause. Although every aspect of the donor surgery is
important, the patient’s postoperative pain experience
should not be overlooked. Patients’ experiences in the
immediate postoperative period often shape their re-
covery trajectories, their ability to resume normal
activities, and their willingness to recommend live
liver donation to other healthy, highly functioning
individuals. A painful experience could conceivably
limit a patient’s willingness to recommend this altru-
istic act to others who may be considering potential
liver donation.43 Given that previous studies have
demonstrated a higher incidence of postoperative pain
than patients had anticipated,43-45 this aspect of the
liver transplant experience demands future attention.
Epidural analgesia is extremely safe; however, the
literature does report a very low risk of patients devel-
oping an epidural hematoma (ie, 1:150,000
patients).46,47 Although epidural hematomas are
extremely rare, the consequences can be catastrophic
with paralysis as the result. Postoperative coagulop-
athy can occur in a subset of patients (manifested as
a transient prolongation of international normalized
ratio and prothrombin times),48 which could poten-
tially increase the risk of developing an epidural
TABLE 4. Incidence of Sedation
Postoperative
Day and Time i.v. PCA (%) PCEA (%) P Value
POD0 18:00 79.0 61.6 0.02*
POD0 24:00 80.6 61.9 0.004*
POD1 6:00 58.1 43.9 0.05
POD1 12:00 44.4 36.9 0.31
POD1 18:00 39.4 30.3 0.21
POD1 24:00 59.1 46.7 0.11
POD2 06:00 45.9 33.9 0.12
POD2 12:00 45.7 25.9 0.01*
POD2 18:00 36.1 18.9 0.03*
POD2 24:00 54.5 46.5 0.46
POD3 06:00 48.1 23.4 0.004*
POD ¼ Postoperative Day.
*Indicates significant difference P < 0.05.
TABLE 5. Incidence of Pruritus
Postoperative
Day and Time i.v. PCA (%) PCEA (%) P Value
POD0 18:00 2.4 3.3 0.66
POD0 24:00 0.0 0.0 n/a
POD1 6:00 3.2 16.4 0.001*
POD1 12:00 4.9 13.6 0.04*
POD1 18:00 2.12 15.1 0.0008*
POD1 24:00 3.8 10.0 0.1
POD2 06:00 7.0 10.1 0.56
POD2 12:00 5.2 9.3 0.3
POD2 18:00 5.7 15.1 0.07
POD2 24:00 2.1 14.3 0.01*
POD3 06:00 2.9 4.3 0.7
POD ¼ Postoperative Day.
*Indicates significant difference P < 0.05.
hematoma, although to our knowledge, there have
been no published reports of epidural hematomas af-
ter live liver donor surgeries. Unfortunately, the very
rare incidence of an epidural hematoma precludes the
study of this adverse event in a prospective trial. A
report that reviewed the use of epidural analgesia for
live liver donors found that although the coagulation
profiles were abnormal in some patients, values
returned to baseline by POD3 and there were no
reports of epidural hematomas.48
At our institution, of the 226 live liver donor opera-
tions analyzed, only 68 patients received epidural an-
algesia as their primary analgesic modality. This gen-
eral trend is not surprising given the reluctance of the
perioperative team to expose such highly functioning
patients to the risk of a catastrophic event. In recent
years, epidural analgesia has become more popular
with anesthesiologists for hepatic carcinoma resec-
tions.24,49 Clearly, the safety of epidural analgesia af-
ter live liver donation requires further study.
Animal models have demonstrated that acute he-
patic failure causes increased plasma levels of sys-
temic opioids50; therefore, sedation following liver
resection may be an early sign of liver insufficiency.
Table 1 demonstrates that patients without PCEA
received significantly more opioids intraoperatively,
which most likely added to the increased sedation
found at POD0 18:00 (Table 4). However, beyond that
initial time point, the increased interval opioid usage
by the IV PCA group is presented in Fig. 1 and is con-
gruent with the increased sedation demonstrated by
this group in Table 4. Our current results are sup-
ported by a previous study that also found that the
use of PCEA for primary pain relief after liver resec-
tion has reduced the amount of systemic opioids
administered to patients by more than 50%.51 The
increased incidence of pruritus (Table 5) reported by
the PCEA group can be improved by removing the
opioid from our epidural solutions. Furthermore, the
use of an opioid-free epidural may not only offer
excellent pain control, it may also reduce side effects
and should not affect liver function or the ability of
the transplant team to detect early liver insufficiency.
There are several limitations to our retrospective
analysis. First, given the retrospective nature of the
data collected, adequate standardization of postopera-
tive care was unlikely. Second, coagulation profiles of
our patients were not collected because it was not one
of the aims of our study. Limited coagulation profile
data, even if collected in our population, would likely
be insignificant with respect to determining the risk of
perioperative bleeding and the potential risks associ-
ated with the development of an epidural hematoma.
Finally, pain data were not available after patients
were discharged from the APS.
The results of this study demonstrate that the use
of PCEA significantly reduces moderate pain in the
early postoperative period among patients who had
undergone living donor hepatectomy when compared
to use of IV PCA. Significant pain relief was noted up
to the morning of postoperative day 3. Ongoing
research is being conducted by the Adult to Adult Liv-
ing Donor Liver Transplantation (A2ALL) Consortium
with respect to long-term health-related quality of life
after live liver donation. It is imperative that the fol-
lowing aspects of live liver donation surgery be thor-
oughly investigated: pain experience, the potential
risks/benefits of epidural analgesia relative to other
analgesic modalities, and that the physical, psycho-
logical, and long-term effects on the functioning of
these patients continue to be documented. The remote
possibility of the occurrence of an epidural hematoma
is not sufficient rationale to dismiss this modality of
pain control for all patients undergoing live liver dona-
tion. Collecting data in a prospective manner would
help to validate or refute the current results and
improve patient preoperative awareness and informed
consent for live liver donation.
TABLE 6. Incidence of Nausea
Postoperative
Day and Time i.v. PCA (%) PCEA (%) P Value
POD0 18:00 4.8 8.3 0.34
POD0 24:00 3.5 3.1 1.0
POD1 6:00 4.4 2.9 0.72
POD1 12:00 4.9 7.5 0.52
POD1 18:00 1.4 3.0 0.59
POD1 24:00 1.5 1.6 1.0
POD2 06:00 7.0 3.3 0.56
POD2 12:00 11.3 5.6 0.39
POD2 18:00 6.6 3.8 0.72
POD2 24:00 4.1 2.4 1.0
POD3 06:00 3.0 12.8 0.03*
POD ¼ Postoperative Day.
*Indicates significant difference P < 0.05.
TABLE 7. Postoperative Milestones
Variable N i.v. PCA N PCEA P Value
Commencing fluid sips (days) 125 1.6 6 1.0 52 1.6 6 0.9 0.9
Time to ambulation (days) 127 1.8 6 1.0 56 1.9 6 1.0 0.22
Length of hospital stay (days) 158 6.5 6 1.7 68 6.6 6 1.7 0.69
Data are mean 6 SD. Significant differences were not found between groups.
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